nodes	percent_of_prediction	percent_of_DWPC	metapath
Cilazapril—Nateglinide—Bortezomib—hematologic cancer	0.352	1	CrCrCtD
Cilazapril—ABCB1—hematologic cancer	0.141	1	CbGaD
Cilazapril—ABCB1—Lenalidomide—hematologic cancer	0.0341	0.141	CbGbCtD
Cilazapril—ABCB1—Daunorubicin—hematologic cancer	0.02	0.0826	CbGbCtD
Cilazapril—ABCB1—Alitretinoin—hematologic cancer	0.0196	0.0809	CbGbCtD
Cilazapril—ABCB1—Imatinib—hematologic cancer	0.0153	0.0633	CbGbCtD
Cilazapril—ABCB1—Nilotinib—hematologic cancer	0.0139	0.0575	CbGbCtD
Cilazapril—ABCB1—Vinorelbine—hematologic cancer	0.0138	0.057	CbGbCtD
Cilazapril—ABCB1—Dasatinib—hematologic cancer	0.0123	0.0508	CbGbCtD
Cilazapril—ABCB1—Mitoxantrone—hematologic cancer	0.0122	0.0502	CbGbCtD
Cilazapril—ABCB1—Betamethasone—hematologic cancer	0.0108	0.0447	CbGbCtD
Cilazapril—ABCB1—Gemcitabine—hematologic cancer	0.0107	0.0443	CbGbCtD
Cilazapril—ABCB1—Prednisolone—hematologic cancer	0.0107	0.0442	CbGbCtD
Cilazapril—ABCB1—Prednisone—hematologic cancer	0.0101	0.0417	CbGbCtD
Cilazapril—ABCB1—Irinotecan—hematologic cancer	0.00958	0.0395	CbGbCtD
Cilazapril—ABCB1—Vinblastine—hematologic cancer	0.00852	0.0351	CbGbCtD
Cilazapril—ABCB1—Vincristine—hematologic cancer	0.00837	0.0345	CbGbCtD
Cilazapril—ABCB1—Cisplatin—hematologic cancer	0.00781	0.0322	CbGbCtD
Cilazapril—ABCB1—Etoposide—hematologic cancer	0.00767	0.0317	CbGbCtD
Cilazapril—ABCB1—Dexamethasone—hematologic cancer	0.00631	0.026	CbGbCtD
Cilazapril—ABCB1—Doxorubicin—hematologic cancer	0.00523	0.0216	CbGbCtD
Cilazapril—ABCB1—Methotrexate—hematologic cancer	0.00507	0.0209	CbGbCtD
Cilazapril—Benazepril—MTHFR—hematologic cancer	0.000289	0.446	CrCbGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—MCL1—hematologic cancer	0.000125	0.00366	CbGpPWpGaD
Cilazapril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CCND3—hematologic cancer	0.000122	0.00358	CbGpPWpGaD
Cilazapril—Perindopril—ABCB1—hematologic cancer	0.00012	0.185	CrCbGaD
Cilazapril—ACE—Metabolism of proteins—MUC1—hematologic cancer	0.000118	0.00348	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—FXYD6—hematologic cancer	0.000117	0.00344	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—AQP9—hematologic cancer	0.000117	0.00344	CbGpPWpGaD
Cilazapril—ABCB1—Constitutive Androstane Receptor Pathway—HSP90AA1—hematologic cancer	0.000114	0.00336	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—CA9—hematologic cancer	0.000114	0.00334	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—CXCR5—hematologic cancer	0.000112	0.00328	CbGpPWpGaD
Cilazapril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—ABCG2—hematologic cancer	0.00011	0.00322	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—FXYD6—hematologic cancer	0.000109	0.0032	CbGpPWpGaD
Cilazapril—Lisinopril—ABCB1—hematologic cancer	0.000106	0.163	CrCbGaD
Cilazapril—ACE—Metabolism of proteins—RPLP1—hematologic cancer	0.000103	0.00304	CbGpPWpGaD
Cilazapril—SLC15A2—SLC-mediated transmembrane transport—SLC22A1—hematologic cancer	0.000103	0.00303	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—CXCL13—hematologic cancer	9.86e-05	0.0029	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—NPM1—hematologic cancer	9.77e-05	0.00287	CbGpPWpGaD
Cilazapril—SLC15A2—SLC-mediated transmembrane transport—NUP98—hematologic cancer	9.73e-05	0.00286	CbGpPWpGaD
Cilazapril—SLC15A1—SLC-mediated transmembrane transport—SLC22A1—hematologic cancer	9.57e-05	0.00281	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—S100A10—hematologic cancer	9.56e-05	0.00281	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—TUBB2A—hematologic cancer	9.5e-05	0.00279	CbGpPWpGaD
Cilazapril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—EPO—hematologic cancer	9.4e-05	0.00276	CbGpPWpGaD
Cilazapril—SLC15A2—SLC-mediated transmembrane transport—NUP214—hematologic cancer	9.38e-05	0.00275	CbGpPWpGaD
Cilazapril—ABCB1—Constitutive Androstane Receptor Pathway—FOXO1—hematologic cancer	9.1e-05	0.00267	CbGpPWpGaD
Cilazapril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—hematologic cancer	9.08e-05	0.00267	CbGpPWpGaD
Cilazapril—SLC15A1—SLC-mediated transmembrane transport—NUP98—hematologic cancer	9.03e-05	0.00265	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	8.89e-05	0.00261	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—S100A10—hematologic cancer	8.87e-05	0.0026	CbGpPWpGaD
Cilazapril—SLC15A1—SLC-mediated transmembrane transport—NUP214—hematologic cancer	8.7e-05	0.00256	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—ABCG2—hematologic cancer	8.63e-05	0.00253	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—FOXP3—hematologic cancer	8.46e-05	0.00248	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—MME—hematologic cancer	8.43e-05	0.00248	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	8.36e-05	0.00245	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—SUMO1—hematologic cancer	8.34e-05	0.00245	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—CMA1—hematologic cancer	8.34e-05	0.00245	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	8.25e-05	0.00242	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—SPHK1—hematologic cancer	8.16e-05	0.0024	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	7.92e-05	0.00233	CbGpPWpGaD
Cilazapril—Enalapril—ABCB1—hematologic cancer	7.77e-05	0.12	CrCbGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	7.75e-05	0.00228	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—TFRC—hematologic cancer	7.69e-05	0.00226	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—EPO—hematologic cancer	7.41e-05	0.00217	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	7.35e-05	0.00216	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—RPS14—hematologic cancer	7.31e-05	0.00215	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—ATP4A—hematologic cancer	7.24e-05	0.00213	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—ANXA2—hematologic cancer	7.24e-05	0.00213	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—SGK1—hematologic cancer	7.24e-05	0.00213	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—GZMB—hematologic cancer	7.24e-05	0.00213	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—IL13—hematologic cancer	7.24e-05	0.00213	CbGpPWpGaD
Cilazapril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—ABL1—hematologic cancer	7.06e-05	0.00207	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—CXCR4—hematologic cancer	6.9e-05	0.00203	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—ANXA2—hematologic cancer	6.72e-05	0.00197	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—ATP4A—hematologic cancer	6.72e-05	0.00197	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—SGK1—hematologic cancer	6.72e-05	0.00197	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—CASP7—hematologic cancer	6.63e-05	0.00195	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	6.52e-05	0.00192	CbGpPWpGaD
Cilazapril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRB—hematologic cancer	6.46e-05	0.0019	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—TOP1—hematologic cancer	6.42e-05	0.00189	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—PRKCZ—hematologic cancer	6.41e-05	0.00188	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—EIF4EBP1—hematologic cancer	6.39e-05	0.00188	CbGpPWpGaD
Cilazapril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—hematologic cancer	6.36e-05	0.00187	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	6.05e-05	0.00178	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—HSPA5—hematologic cancer	5.91e-05	0.00174	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—CD40—hematologic cancer	5.91e-05	0.00174	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—CALR—hematologic cancer	5.73e-05	0.00168	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—ABCC3—hematologic cancer	5.73e-05	0.00168	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—RARA—hematologic cancer	5.73e-05	0.00168	CbGpPWpGaD
Cilazapril—Nateglinide—ALB—hematologic cancer	5.56e-05	0.0858	CrCbGaD
Cilazapril—ACE—Metabolism of proteins—FBXW7—hematologic cancer	5.54e-05	0.00163	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—STAT1—hematologic cancer	5.36e-05	0.00157	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—ABCC3—hematologic cancer	5.31e-05	0.00156	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	5.24e-05	0.00154	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—HLA-DQA1—hematologic cancer	5.13e-05	0.00151	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—NUP98—hematologic cancer	4.94e-05	0.00145	CbGpPWpGaD
Cilazapril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—hematologic cancer	4.93e-05	0.00145	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	4.86e-05	0.00143	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—ADCY7—hematologic cancer	4.8e-05	0.00141	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—NUP214—hematologic cancer	4.77e-05	0.0014	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—BBC3—hematologic cancer	4.74e-05	0.00139	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—ABCG2—hematologic cancer	4.67e-05	0.00137	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—CD86—hematologic cancer	4.62e-05	0.00136	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—TERT—hematologic cancer	4.61e-05	0.00135	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—NUP98—hematologic cancer	4.59e-05	0.00135	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—IL10—hematologic cancer	4.53e-05	0.00133	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—CD40LG—hematologic cancer	4.53e-05	0.00133	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—ADCY7—hematologic cancer	4.45e-05	0.00131	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—NUP214—hematologic cancer	4.42e-05	0.0013	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—IL4—hematologic cancer	4.41e-05	0.00129	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—PDGFRA—hematologic cancer	4.34e-05	0.00127	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—ABCG2—hematologic cancer	4.33e-05	0.00127	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—HLA-B—hematologic cancer	4.31e-05	0.00126	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—JUND—hematologic cancer	4.25e-05	0.00125	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—FASLG—hematologic cancer	4.21e-05	0.00124	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—TFRC—hematologic cancer	4.16e-05	0.00122	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—FAS—hematologic cancer	4.06e-05	0.00119	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—IL2RA—hematologic cancer	4.04e-05	0.00119	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—hematologic cancer	4.03e-05	0.00118	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—HLA-A—hematologic cancer	3.99e-05	0.00117	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—AQP9—hematologic cancer	3.96e-05	0.00116	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—TFRC—hematologic cancer	3.86e-05	0.00113	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—hematologic cancer	3.82e-05	0.00112	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—FOS—hematologic cancer	3.7e-05	0.00109	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—CREB1—hematologic cancer	3.7e-05	0.00109	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—FXYD6—hematologic cancer	3.68e-05	0.00108	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—CREBBP—hematologic cancer	3.6e-05	0.00106	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—PML—hematologic cancer	3.6e-05	0.00106	CbGpPWpGaD
Cilazapril—SLC15A2—SLC-mediated transmembrane transport—ALB—hematologic cancer	3.59e-05	0.00105	CbGpPWpGaD
Cilazapril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—hematologic cancer	3.54e-05	0.00104	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—CYCS—hematologic cancer	3.49e-05	0.00103	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—CD80—hematologic cancer	3.37e-05	0.000989	CbGpPWpGaD
Cilazapril—SLC15A1—SLC-mediated transmembrane transport—ALB—hematologic cancer	3.33e-05	0.000977	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—hematologic cancer	3.29e-05	0.000965	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—CASP7—hematologic cancer	3.27e-05	0.000961	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—CYCS—hematologic cancer	3.24e-05	0.000952	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—CASP8—hematologic cancer	3.13e-05	0.00092	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—hematologic cancer	3.12e-05	0.000917	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—S100A10—hematologic cancer	3e-05	0.000881	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—ABCB1—hematologic cancer	2.91e-05	0.000855	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—CCL2—hematologic cancer	2.85e-05	0.000836	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—hematologic cancer	2.84e-05	0.000835	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	2.79e-05	0.000819	CbGpPWpGaD
Cilazapril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—hematologic cancer	2.71e-05	0.000796	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—ABCB1—hematologic cancer	2.7e-05	0.000794	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—IFNG—hematologic cancer	2.66e-05	0.000782	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—JUN—hematologic cancer	2.66e-05	0.000781	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—STAT1—hematologic cancer	2.64e-05	0.000776	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	2.62e-05	0.00077	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—AR—hematologic cancer	2.56e-05	0.000751	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	2.49e-05	0.00073	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—GRB2—hematologic cancer	2.47e-05	0.000726	CbGpPWpGaD
Cilazapril—Gastrointestinal disorder—Betamethasone—hematologic cancer	2.47e-05	0.000107	CcSEcCtD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFA—hematologic cancer	2.47e-05	0.000724	CbGpPWpGaD
Cilazapril—Fatigue—Dexamethasone—hematologic cancer	2.47e-05	0.000107	CcSEcCtD
Cilazapril—Fatigue—Betamethasone—hematologic cancer	2.47e-05	0.000107	CcSEcCtD
Cilazapril—Chills—Epirubicin—hematologic cancer	2.46e-05	0.000107	CcSEcCtD
Cilazapril—Pruritus—Etoposide—hematologic cancer	2.46e-05	0.000107	CcSEcCtD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—EP300—hematologic cancer	2.45e-05	0.00072	CbGpPWpGaD
Cilazapril—Shock—Prednisone—hematologic cancer	2.45e-05	0.000107	CcSEcCtD
Cilazapril—Arrhythmia—Epirubicin—hematologic cancer	2.45e-05	0.000106	CcSEcCtD
Cilazapril—Pain—Betamethasone—hematologic cancer	2.45e-05	0.000106	CcSEcCtD
Cilazapril—Pain—Dexamethasone—hematologic cancer	2.45e-05	0.000106	CcSEcCtD
Cilazapril—Visual impairment—Doxorubicin—hematologic cancer	2.44e-05	0.000106	CcSEcCtD
Cilazapril—Tachycardia—Prednisone—hematologic cancer	2.43e-05	0.000106	CcSEcCtD
Cilazapril—Alopecia—Epirubicin—hematologic cancer	2.42e-05	0.000105	CcSEcCtD
Cilazapril—Skin disorder—Prednisone—hematologic cancer	2.42e-05	0.000105	CcSEcCtD
Cilazapril—Nausea—Gemcitabine—hematologic cancer	2.42e-05	0.000105	CcSEcCtD
Cilazapril—Vomiting—Cisplatin—hematologic cancer	2.41e-05	0.000105	CcSEcCtD
Cilazapril—Hyperhidrosis—Prednisone—hematologic cancer	2.41e-05	0.000105	CcSEcCtD
Cilazapril—Erythema multiforme—Doxorubicin—hematologic cancer	2.4e-05	0.000104	CcSEcCtD
Cilazapril—Rash—Cisplatin—hematologic cancer	2.39e-05	0.000104	CcSEcCtD
Cilazapril—Dermatitis—Cisplatin—hematologic cancer	2.39e-05	0.000104	CcSEcCtD
Cilazapril—Diarrhoea—Etoposide—hematologic cancer	2.38e-05	0.000103	CcSEcCtD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—STAT5A—hematologic cancer	2.38e-05	0.000698	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—hematologic cancer	2.38e-05	0.000698	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—IL1B—hematologic cancer	2.38e-05	0.000698	CbGpPWpGaD
Cilazapril—Anorexia—Prednisone—hematologic cancer	2.37e-05	0.000103	CcSEcCtD
Cilazapril—ABCB1—Allograft Rejection—CASP3—hematologic cancer	2.37e-05	0.000696	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—IL2—hematologic cancer	2.37e-05	0.000695	CbGpPWpGaD
Cilazapril—Ill-defined disorder—Methotrexate—hematologic cancer	2.37e-05	0.000103	CcSEcCtD
Cilazapril—Tinnitus—Doxorubicin—hematologic cancer	2.37e-05	0.000103	CcSEcCtD
Cilazapril—Anaemia—Methotrexate—hematologic cancer	2.36e-05	0.000102	CcSEcCtD
Cilazapril—Feeling abnormal—Betamethasone—hematologic cancer	2.36e-05	0.000102	CcSEcCtD
Cilazapril—Feeling abnormal—Dexamethasone—hematologic cancer	2.36e-05	0.000102	CcSEcCtD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—hematologic cancer	2.36e-05	0.000692	CbGpPWpGaD
Cilazapril—Flushing—Doxorubicin—hematologic cancer	2.35e-05	0.000102	CcSEcCtD
Cilazapril—Cardiac disorder—Doxorubicin—hematologic cancer	2.35e-05	0.000102	CcSEcCtD
Cilazapril—Flatulence—Epirubicin—hematologic cancer	2.35e-05	0.000102	CcSEcCtD
Cilazapril—Tension—Epirubicin—hematologic cancer	2.34e-05	0.000102	CcSEcCtD
Cilazapril—Gastrointestinal pain—Betamethasone—hematologic cancer	2.34e-05	0.000102	CcSEcCtD
Cilazapril—Gastrointestinal pain—Dexamethasone—hematologic cancer	2.34e-05	0.000102	CcSEcCtD
Cilazapril—Dysgeusia—Epirubicin—hematologic cancer	2.34e-05	0.000102	CcSEcCtD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—VEGFA—hematologic cancer	2.32e-05	0.000682	CbGpPWpGaD
Cilazapril—Hypersensitivity—Triamcinolone—hematologic cancer	2.32e-05	0.000101	CcSEcCtD
Cilazapril—Nervousness—Epirubicin—hematologic cancer	2.32e-05	0.000101	CcSEcCtD
Cilazapril—Angiopathy—Doxorubicin—hematologic cancer	2.3e-05	0.0001	CcSEcCtD
Cilazapril—Malaise—Methotrexate—hematologic cancer	2.3e-05	0.0001	CcSEcCtD
Cilazapril—Dizziness—Etoposide—hematologic cancer	2.3e-05	9.99e-05	CcSEcCtD
Cilazapril—Muscle spasms—Epirubicin—hematologic cancer	2.29e-05	9.97e-05	CcSEcCtD
Cilazapril—Immune system disorder—Doxorubicin—hematologic cancer	2.29e-05	9.96e-05	CcSEcCtD
Cilazapril—Vertigo—Methotrexate—hematologic cancer	2.29e-05	9.96e-05	CcSEcCtD
Cilazapril—Leukopenia—Methotrexate—hematologic cancer	2.28e-05	9.92e-05	CcSEcCtD
Cilazapril—Chills—Doxorubicin—hematologic cancer	2.28e-05	9.89e-05	CcSEcCtD
Cilazapril—ABCB1—Transmembrane transport of small molecules—ANXA2—hematologic cancer	2.27e-05	0.000667	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—SGK1—hematologic cancer	2.27e-05	0.000667	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—ATP4A—hematologic cancer	2.27e-05	0.000667	CbGpPWpGaD
Cilazapril—Urticaria—Dexamethasone—hematologic cancer	2.27e-05	9.88e-05	CcSEcCtD
Cilazapril—Urticaria—Betamethasone—hematologic cancer	2.27e-05	9.88e-05	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Prednisone—hematologic cancer	2.27e-05	9.86e-05	CcSEcCtD
Cilazapril—Dizziness—Prednisolone—hematologic cancer	2.27e-05	9.85e-05	CcSEcCtD
Cilazapril—Arrhythmia—Doxorubicin—hematologic cancer	2.27e-05	9.85e-05	CcSEcCtD
Cilazapril—Asthenia—Triamcinolone—hematologic cancer	2.26e-05	9.83e-05	CcSEcCtD
Cilazapril—Abdominal pain—Betamethasone—hematologic cancer	2.26e-05	9.83e-05	CcSEcCtD
Cilazapril—Abdominal pain—Dexamethasone—hematologic cancer	2.26e-05	9.83e-05	CcSEcCtD
Cilazapril—Nausea—Cisplatin—hematologic cancer	2.25e-05	9.79e-05	CcSEcCtD
Cilazapril—Insomnia—Prednisone—hematologic cancer	2.25e-05	9.79e-05	CcSEcCtD
Cilazapril—Alopecia—Doxorubicin—hematologic cancer	2.24e-05	9.74e-05	CcSEcCtD
Cilazapril—Paraesthesia—Prednisone—hematologic cancer	2.24e-05	9.72e-05	CcSEcCtD
Cilazapril—Pruritus—Triamcinolone—hematologic cancer	2.23e-05	9.69e-05	CcSEcCtD
Cilazapril—Cough—Methotrexate—hematologic cancer	2.23e-05	9.67e-05	CcSEcCtD
Cilazapril—Ill-defined disorder—Epirubicin—hematologic cancer	2.21e-05	9.63e-05	CcSEcCtD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—FGF1—hematologic cancer	2.21e-05	0.000649	CbGpPWpGaD
Cilazapril—Vomiting—Etoposide—hematologic cancer	2.21e-05	9.6e-05	CcSEcCtD
Cilazapril—Anaemia—Epirubicin—hematologic cancer	2.21e-05	9.59e-05	CcSEcCtD
Cilazapril—Dyspepsia—Prednisone—hematologic cancer	2.19e-05	9.53e-05	CcSEcCtD
Cilazapril—Rash—Etoposide—hematologic cancer	2.19e-05	9.52e-05	CcSEcCtD
Cilazapril—Dermatitis—Etoposide—hematologic cancer	2.19e-05	9.52e-05	CcSEcCtD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—hematologic cancer	2.18e-05	0.00064	CbGpPWpGaD
Cilazapril—Headache—Etoposide—hematologic cancer	2.18e-05	9.46e-05	CcSEcCtD
Cilazapril—Flatulence—Doxorubicin—hematologic cancer	2.18e-05	9.46e-05	CcSEcCtD
Cilazapril—Arthralgia—Methotrexate—hematologic cancer	2.17e-05	9.44e-05	CcSEcCtD
Cilazapril—Chest pain—Methotrexate—hematologic cancer	2.17e-05	9.44e-05	CcSEcCtD
Cilazapril—Myalgia—Methotrexate—hematologic cancer	2.17e-05	9.44e-05	CcSEcCtD
Cilazapril—Tension—Doxorubicin—hematologic cancer	2.17e-05	9.42e-05	CcSEcCtD
Cilazapril—Decreased appetite—Prednisone—hematologic cancer	2.17e-05	9.41e-05	CcSEcCtD
Cilazapril—Dysgeusia—Doxorubicin—hematologic cancer	2.16e-05	9.4e-05	CcSEcCtD
Cilazapril—Rash—Prednisolone—hematologic cancer	2.16e-05	9.39e-05	CcSEcCtD
Cilazapril—Dermatitis—Prednisolone—hematologic cancer	2.16e-05	9.38e-05	CcSEcCtD
Cilazapril—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	2.16e-05	9.37e-05	CcSEcCtD
Cilazapril—Malaise—Epirubicin—hematologic cancer	2.15e-05	9.36e-05	CcSEcCtD
Cilazapril—Fatigue—Prednisone—hematologic cancer	2.15e-05	9.33e-05	CcSEcCtD
Cilazapril—Headache—Prednisolone—hematologic cancer	2.15e-05	9.33e-05	CcSEcCtD
Cilazapril—Discomfort—Methotrexate—hematologic cancer	2.15e-05	9.33e-05	CcSEcCtD
Cilazapril—Nervousness—Doxorubicin—hematologic cancer	2.15e-05	9.32e-05	CcSEcCtD
Cilazapril—Vertigo—Epirubicin—hematologic cancer	2.14e-05	9.32e-05	CcSEcCtD
Cilazapril—Syncope—Epirubicin—hematologic cancer	2.14e-05	9.3e-05	CcSEcCtD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—hematologic cancer	2.14e-05	0.000628	CbGpPWpGaD
Cilazapril—Leukopenia—Epirubicin—hematologic cancer	2.14e-05	9.29e-05	CcSEcCtD
Cilazapril—Constipation—Prednisone—hematologic cancer	2.13e-05	9.26e-05	CcSEcCtD
Cilazapril—Muscle spasms—Doxorubicin—hematologic cancer	2.12e-05	9.23e-05	CcSEcCtD
Cilazapril—Palpitations—Epirubicin—hematologic cancer	2.11e-05	9.17e-05	CcSEcCtD
Cilazapril—Confusional state—Methotrexate—hematologic cancer	2.1e-05	9.12e-05	CcSEcCtD
Cilazapril—Loss of consciousness—Epirubicin—hematologic cancer	2.1e-05	9.12e-05	CcSEcCtD
Cilazapril—Dizziness—Triamcinolone—hematologic cancer	2.08e-05	9.06e-05	CcSEcCtD
Cilazapril—Cough—Epirubicin—hematologic cancer	2.08e-05	9.05e-05	CcSEcCtD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—hematologic cancer	2.08e-05	0.00061	CbGpPWpGaD
Cilazapril—Nausea—Etoposide—hematologic cancer	2.06e-05	8.97e-05	CcSEcCtD
Cilazapril—Hypertension—Epirubicin—hematologic cancer	2.06e-05	8.96e-05	CcSEcCtD
Cilazapril—Feeling abnormal—Prednisone—hematologic cancer	2.05e-05	8.92e-05	CcSEcCtD
Cilazapril—Asthenia—Dexamethasone—hematologic cancer	2.05e-05	8.92e-05	CcSEcCtD
Cilazapril—Asthenia—Betamethasone—hematologic cancer	2.05e-05	8.92e-05	CcSEcCtD
Cilazapril—Ill-defined disorder—Doxorubicin—hematologic cancer	2.05e-05	8.91e-05	CcSEcCtD
Cilazapril—ABCB1—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	2.05e-05	0.000601	CbGpPWpGaD
Cilazapril—Anaemia—Doxorubicin—hematologic cancer	2.04e-05	8.87e-05	CcSEcCtD
Cilazapril—Thrombocytopenia—Methotrexate—hematologic cancer	2.04e-05	8.86e-05	CcSEcCtD
Cilazapril—Gastrointestinal pain—Prednisone—hematologic cancer	2.04e-05	8.85e-05	CcSEcCtD
Cilazapril—Nausea—Prednisolone—hematologic cancer	2.04e-05	8.85e-05	CcSEcCtD
Cilazapril—Chest pain—Epirubicin—hematologic cancer	2.03e-05	8.83e-05	CcSEcCtD
Cilazapril—Arthralgia—Epirubicin—hematologic cancer	2.03e-05	8.83e-05	CcSEcCtD
Cilazapril—Myalgia—Epirubicin—hematologic cancer	2.03e-05	8.83e-05	CcSEcCtD
Cilazapril—ABCB1—Metabolism—GMPS—hematologic cancer	2.03e-05	0.000595	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—FTCD—hematologic cancer	2.03e-05	0.000595	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—PHYH—hematologic cancer	2.03e-05	0.000595	CbGpPWpGaD
Cilazapril—Anxiety—Epirubicin—hematologic cancer	2.03e-05	8.8e-05	CcSEcCtD
Cilazapril—Pruritus—Betamethasone—hematologic cancer	2.02e-05	8.8e-05	CcSEcCtD
Cilazapril—Pruritus—Dexamethasone—hematologic cancer	2.02e-05	8.8e-05	CcSEcCtD
Cilazapril—Skin disorder—Methotrexate—hematologic cancer	2.02e-05	8.79e-05	CcSEcCtD
Cilazapril—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	2.02e-05	8.77e-05	CcSEcCtD
Cilazapril—Hyperhidrosis—Methotrexate—hematologic cancer	2.01e-05	8.75e-05	CcSEcCtD
Cilazapril—ABCB1—Allograft Rejection—VEGFA—hematologic cancer	2.01e-05	0.000591	CbGpPWpGaD
Cilazapril—Discomfort—Epirubicin—hematologic cancer	2.01e-05	8.73e-05	CcSEcCtD
Cilazapril—Vomiting—Triamcinolone—hematologic cancer	2e-05	8.71e-05	CcSEcCtD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—hematologic cancer	2e-05	0.000588	CbGpPWpGaD
Cilazapril—Malaise—Doxorubicin—hematologic cancer	1.99e-05	8.66e-05	CcSEcCtD
Cilazapril—Rash—Triamcinolone—hematologic cancer	1.99e-05	8.64e-05	CcSEcCtD
Cilazapril—Dry mouth—Epirubicin—hematologic cancer	1.99e-05	8.64e-05	CcSEcCtD
Cilazapril—Dermatitis—Triamcinolone—hematologic cancer	1.99e-05	8.63e-05	CcSEcCtD
Cilazapril—Vertigo—Doxorubicin—hematologic cancer	1.98e-05	8.62e-05	CcSEcCtD
Cilazapril—Anorexia—Methotrexate—hematologic cancer	1.98e-05	8.62e-05	CcSEcCtD
Cilazapril—Syncope—Doxorubicin—hematologic cancer	1.98e-05	8.61e-05	CcSEcCtD
Cilazapril—Urticaria—Prednisone—hematologic cancer	1.98e-05	8.6e-05	CcSEcCtD
Cilazapril—Leukopenia—Doxorubicin—hematologic cancer	1.98e-05	8.59e-05	CcSEcCtD
Cilazapril—Headache—Triamcinolone—hematologic cancer	1.97e-05	8.58e-05	CcSEcCtD
Cilazapril—Abdominal pain—Prednisone—hematologic cancer	1.97e-05	8.56e-05	CcSEcCtD
Cilazapril—Confusional state—Epirubicin—hematologic cancer	1.96e-05	8.54e-05	CcSEcCtD
Cilazapril—Diarrhoea—Betamethasone—hematologic cancer	1.96e-05	8.51e-05	CcSEcCtD
Cilazapril—Diarrhoea—Dexamethasone—hematologic cancer	1.96e-05	8.51e-05	CcSEcCtD
Cilazapril—Palpitations—Doxorubicin—hematologic cancer	1.95e-05	8.48e-05	CcSEcCtD
Cilazapril—Oedema—Epirubicin—hematologic cancer	1.95e-05	8.47e-05	CcSEcCtD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.95e-05	0.000572	CbGpPWpGaD
Cilazapril—Hypotension—Methotrexate—hematologic cancer	1.95e-05	8.45e-05	CcSEcCtD
Cilazapril—Loss of consciousness—Doxorubicin—hematologic cancer	1.94e-05	8.44e-05	CcSEcCtD
Cilazapril—Cough—Doxorubicin—hematologic cancer	1.93e-05	8.38e-05	CcSEcCtD
Cilazapril—Shock—Epirubicin—hematologic cancer	1.92e-05	8.33e-05	CcSEcCtD
Cilazapril—Thrombocytopenia—Epirubicin—hematologic cancer	1.91e-05	8.29e-05	CcSEcCtD
Cilazapril—Hypertension—Doxorubicin—hematologic cancer	1.91e-05	8.29e-05	CcSEcCtD
Cilazapril—Tachycardia—Epirubicin—hematologic cancer	1.9e-05	8.26e-05	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Methotrexate—hematologic cancer	1.9e-05	8.24e-05	CcSEcCtD
Cilazapril—Skin disorder—Epirubicin—hematologic cancer	1.89e-05	8.22e-05	CcSEcCtD
Cilazapril—Dizziness—Dexamethasone—hematologic cancer	1.89e-05	8.22e-05	CcSEcCtD
Cilazapril—Dizziness—Betamethasone—hematologic cancer	1.89e-05	8.22e-05	CcSEcCtD
Cilazapril—Hyperhidrosis—Epirubicin—hematologic cancer	1.88e-05	8.19e-05	CcSEcCtD
Cilazapril—Insomnia—Methotrexate—hematologic cancer	1.88e-05	8.18e-05	CcSEcCtD
Cilazapril—Myalgia—Doxorubicin—hematologic cancer	1.88e-05	8.17e-05	CcSEcCtD
Cilazapril—Chest pain—Doxorubicin—hematologic cancer	1.88e-05	8.17e-05	CcSEcCtD
Cilazapril—Arthralgia—Doxorubicin—hematologic cancer	1.88e-05	8.17e-05	CcSEcCtD
Cilazapril—Anxiety—Doxorubicin—hematologic cancer	1.87e-05	8.14e-05	CcSEcCtD
Cilazapril—Nausea—Triamcinolone—hematologic cancer	1.87e-05	8.14e-05	CcSEcCtD
Cilazapril—Paraesthesia—Methotrexate—hematologic cancer	1.87e-05	8.12e-05	CcSEcCtD
Cilazapril—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	1.87e-05	8.12e-05	CcSEcCtD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—hematologic cancer	1.87e-05	0.000548	CbGpPWpGaD
Cilazapril—Discomfort—Doxorubicin—hematologic cancer	1.86e-05	8.07e-05	CcSEcCtD
Cilazapril—Anorexia—Epirubicin—hematologic cancer	1.86e-05	8.07e-05	CcSEcCtD
Cilazapril—Dyspnoea—Methotrexate—hematologic cancer	1.86e-05	8.07e-05	CcSEcCtD
Cilazapril—ABCB1—Metabolism—SMPD3—hematologic cancer	1.85e-05	0.000544	CbGpPWpGaD
Cilazapril—Somnolence—Methotrexate—hematologic cancer	1.85e-05	8.04e-05	CcSEcCtD
Cilazapril—ABCB1—Allograft Rejection—TGFB1—hematologic cancer	1.85e-05	0.000542	CbGpPWpGaD
Cilazapril—Dry mouth—Doxorubicin—hematologic cancer	1.84e-05	7.99e-05	CcSEcCtD
Cilazapril—Hypersensitivity—Prednisone—hematologic cancer	1.84e-05	7.98e-05	CcSEcCtD
Cilazapril—Dyspepsia—Methotrexate—hematologic cancer	1.83e-05	7.96e-05	CcSEcCtD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—ALB—hematologic cancer	1.82e-05	0.000535	CbGpPWpGaD
Cilazapril—Hypotension—Epirubicin—hematologic cancer	1.82e-05	7.91e-05	CcSEcCtD
Cilazapril—Vomiting—Dexamethasone—hematologic cancer	1.82e-05	7.9e-05	CcSEcCtD
Cilazapril—Vomiting—Betamethasone—hematologic cancer	1.82e-05	7.9e-05	CcSEcCtD
Cilazapril—Confusional state—Doxorubicin—hematologic cancer	1.82e-05	7.9e-05	CcSEcCtD
Cilazapril—Decreased appetite—Methotrexate—hematologic cancer	1.81e-05	7.87e-05	CcSEcCtD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.81e-05	0.000531	CbGpPWpGaD
Cilazapril—Rash—Dexamethasone—hematologic cancer	1.8e-05	7.84e-05	CcSEcCtD
Cilazapril—Rash—Betamethasone—hematologic cancer	1.8e-05	7.84e-05	CcSEcCtD
Cilazapril—Oedema—Doxorubicin—hematologic cancer	1.8e-05	7.83e-05	CcSEcCtD
Cilazapril—Dermatitis—Dexamethasone—hematologic cancer	1.8e-05	7.83e-05	CcSEcCtD
Cilazapril—Dermatitis—Betamethasone—hematologic cancer	1.8e-05	7.83e-05	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Methotrexate—hematologic cancer	1.8e-05	7.81e-05	CcSEcCtD
Cilazapril—ABCB1—Transmembrane transport of small molecules—ABCC3—hematologic cancer	1.8e-05	0.000528	CbGpPWpGaD
Cilazapril—Fatigue—Methotrexate—hematologic cancer	1.79e-05	7.8e-05	CcSEcCtD
Cilazapril—Headache—Dexamethasone—hematologic cancer	1.79e-05	7.79e-05	CcSEcCtD
Cilazapril—Headache—Betamethasone—hematologic cancer	1.79e-05	7.79e-05	CcSEcCtD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK14—hematologic cancer	1.79e-05	0.000525	CbGpPWpGaD
Cilazapril—Asthenia—Prednisone—hematologic cancer	1.79e-05	7.77e-05	CcSEcCtD
Cilazapril—Pain—Methotrexate—hematologic cancer	1.78e-05	7.74e-05	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.77e-05	7.71e-05	CcSEcCtD
Cilazapril—Shock—Doxorubicin—hematologic cancer	1.77e-05	7.71e-05	CcSEcCtD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—hematologic cancer	1.77e-05	0.00052	CbGpPWpGaD
Cilazapril—Thrombocytopenia—Doxorubicin—hematologic cancer	1.76e-05	7.67e-05	CcSEcCtD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—hematologic cancer	1.76e-05	0.000518	CbGpPWpGaD
Cilazapril—Pruritus—Prednisone—hematologic cancer	1.76e-05	7.66e-05	CcSEcCtD
Cilazapril—Insomnia—Epirubicin—hematologic cancer	1.76e-05	7.66e-05	CcSEcCtD
Cilazapril—Tachycardia—Doxorubicin—hematologic cancer	1.76e-05	7.65e-05	CcSEcCtD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—hematologic cancer	1.76e-05	0.000516	CbGpPWpGaD
Cilazapril—Skin disorder—Doxorubicin—hematologic cancer	1.75e-05	7.61e-05	CcSEcCtD
Cilazapril—Paraesthesia—Epirubicin—hematologic cancer	1.75e-05	7.6e-05	CcSEcCtD
Cilazapril—Hyperhidrosis—Doxorubicin—hematologic cancer	1.74e-05	7.57e-05	CcSEcCtD
Cilazapril—Dyspnoea—Epirubicin—hematologic cancer	1.74e-05	7.55e-05	CcSEcCtD
Cilazapril—Somnolence—Epirubicin—hematologic cancer	1.73e-05	7.53e-05	CcSEcCtD
Cilazapril—ABCB1—Allograft Rejection—TNF—hematologic cancer	1.72e-05	0.000506	CbGpPWpGaD
Cilazapril—Anorexia—Doxorubicin—hematologic cancer	1.72e-05	7.47e-05	CcSEcCtD
Cilazapril—Feeling abnormal—Methotrexate—hematologic cancer	1.72e-05	7.46e-05	CcSEcCtD
Cilazapril—Dyspepsia—Epirubicin—hematologic cancer	1.71e-05	7.45e-05	CcSEcCtD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—hematologic cancer	1.71e-05	0.000503	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—hematologic cancer	1.71e-05	0.000503	CbGpPWpGaD
Cilazapril—Diarrhoea—Prednisone—hematologic cancer	1.7e-05	7.41e-05	CcSEcCtD
Cilazapril—Gastrointestinal pain—Methotrexate—hematologic cancer	1.7e-05	7.4e-05	CcSEcCtD
Cilazapril—Nausea—Dexamethasone—hematologic cancer	1.7e-05	7.38e-05	CcSEcCtD
Cilazapril—Nausea—Betamethasone—hematologic cancer	1.7e-05	7.38e-05	CcSEcCtD
Cilazapril—Decreased appetite—Epirubicin—hematologic cancer	1.69e-05	7.36e-05	CcSEcCtD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—ALB—hematologic cancer	1.69e-05	0.000497	CbGpPWpGaD
Cilazapril—Hypotension—Doxorubicin—hematologic cancer	1.68e-05	7.32e-05	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Epirubicin—hematologic cancer	1.68e-05	7.31e-05	CcSEcCtD
Cilazapril—Fatigue—Epirubicin—hematologic cancer	1.68e-05	7.3e-05	CcSEcCtD
Cilazapril—Constipation—Epirubicin—hematologic cancer	1.67e-05	7.24e-05	CcSEcCtD
Cilazapril—Pain—Epirubicin—hematologic cancer	1.67e-05	7.24e-05	CcSEcCtD
Cilazapril—Urticaria—Methotrexate—hematologic cancer	1.65e-05	7.19e-05	CcSEcCtD
Cilazapril—Dizziness—Prednisone—hematologic cancer	1.65e-05	7.16e-05	CcSEcCtD
Cilazapril—Abdominal pain—Methotrexate—hematologic cancer	1.65e-05	7.15e-05	CcSEcCtD
Cilazapril—ABCB1—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	1.64e-05	0.000483	CbGpPWpGaD
Cilazapril—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.64e-05	7.14e-05	CcSEcCtD
Cilazapril—Insomnia—Doxorubicin—hematologic cancer	1.63e-05	7.09e-05	CcSEcCtD
Cilazapril—ABCB1—Metabolism—DCK—hematologic cancer	1.62e-05	0.000476	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—B3GAT1—hematologic cancer	1.62e-05	0.000476	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—ASNS—hematologic cancer	1.62e-05	0.000476	CbGpPWpGaD
Cilazapril—Paraesthesia—Doxorubicin—hematologic cancer	1.62e-05	7.03e-05	CcSEcCtD
Cilazapril—Dyspnoea—Doxorubicin—hematologic cancer	1.61e-05	6.98e-05	CcSEcCtD
Cilazapril—Feeling abnormal—Epirubicin—hematologic cancer	1.61e-05	6.98e-05	CcSEcCtD
Cilazapril—Somnolence—Doxorubicin—hematologic cancer	1.6e-05	6.96e-05	CcSEcCtD
Cilazapril—Gastrointestinal pain—Epirubicin—hematologic cancer	1.59e-05	6.92e-05	CcSEcCtD
Cilazapril—Dyspepsia—Doxorubicin—hematologic cancer	1.59e-05	6.9e-05	CcSEcCtD
Cilazapril—Vomiting—Prednisone—hematologic cancer	1.58e-05	6.88e-05	CcSEcCtD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—CREB1—hematologic cancer	1.58e-05	0.000464	CbGpPWpGaD
Cilazapril—Rash—Prednisone—hematologic cancer	1.57e-05	6.83e-05	CcSEcCtD
Cilazapril—Dermatitis—Prednisone—hematologic cancer	1.57e-05	6.82e-05	CcSEcCtD
Cilazapril—Decreased appetite—Doxorubicin—hematologic cancer	1.57e-05	6.81e-05	CcSEcCtD
Cilazapril—Headache—Prednisone—hematologic cancer	1.56e-05	6.78e-05	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.56e-05	6.76e-05	CcSEcCtD
Cilazapril—Fatigue—Doxorubicin—hematologic cancer	1.55e-05	6.75e-05	CcSEcCtD
Cilazapril—ABCB1—Transmembrane transport of small molecules—NUP98—hematologic cancer	1.55e-05	0.000455	CbGpPWpGaD
Cilazapril—Urticaria—Epirubicin—hematologic cancer	1.55e-05	6.73e-05	CcSEcCtD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—hematologic cancer	1.55e-05	0.000454	CbGpPWpGaD
Cilazapril—Constipation—Doxorubicin—hematologic cancer	1.54e-05	6.7e-05	CcSEcCtD
Cilazapril—Pain—Doxorubicin—hematologic cancer	1.54e-05	6.7e-05	CcSEcCtD
Cilazapril—Abdominal pain—Epirubicin—hematologic cancer	1.54e-05	6.69e-05	CcSEcCtD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—hematologic cancer	1.54e-05	0.000452	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—HDC—hematologic cancer	1.54e-05	0.000451	CbGpPWpGaD
Cilazapril—Hypersensitivity—Methotrexate—hematologic cancer	1.53e-05	6.67e-05	CcSEcCtD
Cilazapril—ABCB1—Transmembrane transport of small molecules—ADCY7—hematologic cancer	1.51e-05	0.000442	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—NUP214—hematologic cancer	1.5e-05	0.000439	CbGpPWpGaD
Cilazapril—Asthenia—Methotrexate—hematologic cancer	1.49e-05	6.49e-05	CcSEcCtD
Cilazapril—Feeling abnormal—Doxorubicin—hematologic cancer	1.49e-05	6.46e-05	CcSEcCtD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—AKT1—hematologic cancer	1.48e-05	0.000435	CbGpPWpGaD
Cilazapril—Nausea—Prednisone—hematologic cancer	1.48e-05	6.43e-05	CcSEcCtD
Cilazapril—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.47e-05	6.41e-05	CcSEcCtD
Cilazapril—Pruritus—Methotrexate—hematologic cancer	1.47e-05	6.4e-05	CcSEcCtD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—hematologic cancer	1.47e-05	0.000431	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—ABCG2—hematologic cancer	1.46e-05	0.00043	CbGpPWpGaD
Cilazapril—Hypersensitivity—Epirubicin—hematologic cancer	1.44e-05	6.24e-05	CcSEcCtD
Cilazapril—Urticaria—Doxorubicin—hematologic cancer	1.43e-05	6.22e-05	CcSEcCtD
Cilazapril—Abdominal pain—Doxorubicin—hematologic cancer	1.42e-05	6.19e-05	CcSEcCtD
Cilazapril—Diarrhoea—Methotrexate—hematologic cancer	1.42e-05	6.19e-05	CcSEcCtD
Cilazapril—ABCB1—Metabolism—CDA—hematologic cancer	1.4e-05	0.000412	CbGpPWpGaD
Cilazapril—Asthenia—Epirubicin—hematologic cancer	1.4e-05	6.07e-05	CcSEcCtD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—hematologic cancer	1.4e-05	0.00041	CbGpPWpGaD
Cilazapril—Pruritus—Epirubicin—hematologic cancer	1.38e-05	5.99e-05	CcSEcCtD
Cilazapril—Dizziness—Methotrexate—hematologic cancer	1.38e-05	5.98e-05	CcSEcCtD
Cilazapril—ABCB1—Metabolism—PC—hematologic cancer	1.35e-05	0.000397	CbGpPWpGaD
Cilazapril—Diarrhoea—Epirubicin—hematologic cancer	1.33e-05	5.79e-05	CcSEcCtD
Cilazapril—Hypersensitivity—Doxorubicin—hematologic cancer	1.33e-05	5.77e-05	CcSEcCtD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—hematologic cancer	1.33e-05	0.000389	CbGpPWpGaD
Cilazapril—Vomiting—Methotrexate—hematologic cancer	1.32e-05	5.75e-05	CcSEcCtD
Cilazapril—Rash—Methotrexate—hematologic cancer	1.31e-05	5.7e-05	CcSEcCtD
Cilazapril—Dermatitis—Methotrexate—hematologic cancer	1.31e-05	5.7e-05	CcSEcCtD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—hematologic cancer	1.31e-05	0.000384	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—SLC35B2—hematologic cancer	1.31e-05	0.000383	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—GBA—hematologic cancer	1.31e-05	0.000383	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—TFRC—hematologic cancer	1.31e-05	0.000383	CbGpPWpGaD
Cilazapril—Headache—Methotrexate—hematologic cancer	1.3e-05	5.67e-05	CcSEcCtD
Cilazapril—Asthenia—Doxorubicin—hematologic cancer	1.29e-05	5.62e-05	CcSEcCtD
Cilazapril—Dizziness—Epirubicin—hematologic cancer	1.29e-05	5.6e-05	CcSEcCtD
Cilazapril—Pruritus—Doxorubicin—hematologic cancer	1.28e-05	5.54e-05	CcSEcCtD
Cilazapril—Vomiting—Epirubicin—hematologic cancer	1.24e-05	5.38e-05	CcSEcCtD
Cilazapril—Nausea—Methotrexate—hematologic cancer	1.24e-05	5.37e-05	CcSEcCtD
Cilazapril—Diarrhoea—Doxorubicin—hematologic cancer	1.23e-05	5.36e-05	CcSEcCtD
Cilazapril—Rash—Epirubicin—hematologic cancer	1.23e-05	5.34e-05	CcSEcCtD
Cilazapril—Dermatitis—Epirubicin—hematologic cancer	1.23e-05	5.33e-05	CcSEcCtD
Cilazapril—Headache—Epirubicin—hematologic cancer	1.22e-05	5.3e-05	CcSEcCtD
Cilazapril—ABCB1—Metabolism—MTAP—hematologic cancer	1.19e-05	0.000351	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—hematologic cancer	1.19e-05	0.00035	CbGpPWpGaD
Cilazapril—Dizziness—Doxorubicin—hematologic cancer	1.19e-05	5.18e-05	CcSEcCtD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—hematologic cancer	1.17e-05	0.000343	CbGpPWpGaD
Cilazapril—Nausea—Epirubicin—hematologic cancer	1.16e-05	5.03e-05	CcSEcCtD
Cilazapril—Vomiting—Doxorubicin—hematologic cancer	1.15e-05	4.98e-05	CcSEcCtD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—hematologic cancer	1.14e-05	0.000334	CbGpPWpGaD
Cilazapril—Rash—Doxorubicin—hematologic cancer	1.14e-05	4.94e-05	CcSEcCtD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—hematologic cancer	1.14e-05	0.000334	CbGpPWpGaD
Cilazapril—Dermatitis—Doxorubicin—hematologic cancer	1.14e-05	4.94e-05	CcSEcCtD
Cilazapril—Headache—Doxorubicin—hematologic cancer	1.13e-05	4.91e-05	CcSEcCtD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—hematologic cancer	1.1e-05	0.000323	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—hematologic cancer	1.1e-05	0.000323	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—CYCS—hematologic cancer	1.1e-05	0.000322	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—hematologic cancer	1.08e-05	0.000316	CbGpPWpGaD
Cilazapril—Nausea—Doxorubicin—hematologic cancer	1.07e-05	4.65e-05	CcSEcCtD
Cilazapril—ABCB1—Metabolism—FHL2—hematologic cancer	1.06e-05	0.000313	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—hematologic cancer	1.05e-05	0.000308	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—AGRN—hematologic cancer	1.04e-05	0.000307	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—hematologic cancer	1.02e-05	0.000299	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—hematologic cancer	9.93e-06	0.000291	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—IDH2—hematologic cancer	9.9e-06	0.000291	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—HMMR—hematologic cancer	9.9e-06	0.000291	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	9.39e-06	0.000276	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—ARNTL—hematologic cancer	9.31e-06	0.000273	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	9.13e-06	0.000268	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	9.11e-06	0.000267	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CA9—hematologic cancer	9.05e-06	0.000266	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—ACP5—hematologic cancer	9.05e-06	0.000266	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—NCOR2—hematologic cancer	8.93e-06	0.000262	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—IDH1—hematologic cancer	8.51e-06	0.00025	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	8.51e-06	0.00025	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	8.44e-06	0.000248	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—GSTO1—hematologic cancer	8.42e-06	0.000247	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—TXN—hematologic cancer	8.42e-06	0.000247	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—ABCC3—hematologic cancer	8.42e-06	0.000247	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—SPHK1—hematologic cancer	8.24e-06	0.000242	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—UGT1A1—hematologic cancer	7.91e-06	0.000232	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	7.75e-06	0.000228	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—SLC22A1—hematologic cancer	7.7e-06	0.000226	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CRABP1—hematologic cancer	7.7e-06	0.000226	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—ALOX5—hematologic cancer	7.5e-06	0.00022	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	7.5e-06	0.00022	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—NUP98—hematologic cancer	7.26e-06	0.000213	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—ADCY7—hematologic cancer	7.05e-06	0.000207	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—NCOA3—hematologic cancer	7.05e-06	0.000207	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—NUP214—hematologic cancer	7e-06	0.000206	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—ABCG2—hematologic cancer	6.86e-06	0.000201	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—MTR—hematologic cancer	6.86e-06	0.000201	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—ENO2—hematologic cancer	6.73e-06	0.000198	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—GSTT1—hematologic cancer	6.53e-06	0.000192	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—SDC1—hematologic cancer	6.38e-06	0.000187	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	6.33e-06	0.000186	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	6.11e-06	0.000179	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	5.72e-06	0.000168	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CD44—hematologic cancer	5.42e-06	0.000159	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—NQO1—hematologic cancer	5.42e-06	0.000159	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CYCS—hematologic cancer	5.13e-06	0.000151	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—HSP90AA1—hematologic cancer	5.1e-06	0.00015	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—GSTP1—hematologic cancer	4.52e-06	0.000133	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—NCOR1—hematologic cancer	4.16e-06	0.000122	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—GSTM1—hematologic cancer	4.16e-06	0.000122	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—MTHFR—hematologic cancer	3.67e-06	0.000108	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—PIK3CG—hematologic cancer	3.09e-06	9.06e-05	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CREBBP—hematologic cancer	2.86e-06	8.4e-05	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—PIK3CD—hematologic cancer	2.71e-06	7.97e-05	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—ALB—hematologic cancer	2.68e-06	7.86e-05	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—PIK3R1—hematologic cancer	2.56e-06	7.52e-05	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—PIK3CB—hematologic cancer	2.37e-06	6.94e-05	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—PTEN—hematologic cancer	2.04e-06	6e-05	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—EP300—hematologic cancer	1.95e-06	5.72e-05	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—PIK3CA—hematologic cancer	1.44e-06	4.23e-05	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—AKT1—hematologic cancer	1.18e-06	3.46e-05	CbGpPWpGaD
